1-855-416-7738 info@preveceutical.com
CSE: PREV OTC: PRVCF FSE: 18H
 
 

PreveCeutical Medical Inc.

About

"Prevention is better than cure." – Desiderius Erasmus

PreveCeutical – word origin preven(tive) + (pharma)ceutical.
preventive | [pri-ven-tiv] noun a medicine or other treatment designed to stop disease or ill health from occurring ceutical | [soo-ti-kuh l] suffix refined healing item or therapy

PreveCeutical™ Medical Inc. is a biomedical company that coined the platform for preventive health sciences. PreveCeutical’s innovative research and development department advances organic and nature identical products for both prevention and curative therapies.

Our Story

2009-2014

Stephen Van Deventer, a seasoned business person and venture capitalist and Kimberly Van Deventer, a successful entrepreneur met in 2009 and formed a business partnership. This was a great meeting of minds. In 2010 they started Cornerstone Global Partners, a venture capital, and business development company.  They were involved in a number of ventures and building companies including Aurora Cannabis Inc.

2015-2016

Steve and Kimberly were very interested in the health and wellness market.  They started looking into utilisation of nature and science for the benefit of health-conscious consumers. With that in mind, they coined the word PreveCeutical™ to which captures the demand for preventive health products and nutraceuticals.  They formed PreveCeutical™ Medical Inc. (“PREV”) a company that was incorporated in British Columbia on October 2nd, 2015.  They were introduced to a therapy which included a polarized scorpion venom treatment which was developed by Dr. Arthur Mikaelian. PREV entered into an agreement for the exclusive worldwide right to manufacture and distribute the blue scorpion venom product under the trade name CELLB9®, which is being marketed and sold by PREV.

Steve and Kimberly raised equity with the help of friends, family and associates which provided the capital to grow the company including creating a team that works with them to further the business purpose.  They continued to look for innovative solutions and products that promote good health and wellness.

Read More

2017

With continued focus on utlitising nature and science, in April 2017 PREV formed a partnership with UniQuest Pty Limited, the main commercialization company for the University of Queensland in which UniQuest will conduct a number of research programs for PREV.  Continued growth in the company has and is fostering amazing partnerships. In May of this year a partnership with Uniquest at the Queensland University was struck; Australia’s leading commercialization entity consistently in the top tier of technology transfer worldwide. With development programs for three exciting therapies underway PreveCeutical™ is moving steadily forward. The team is celebrating the success of their IPO in their new corporate office space.

TEAM MEMBERS

Stephen Van Deventer
Stephen Van Deventer
Chairman, Chief Executive Officer
Kimberly Van Deventer
Kimberly Van Deventer
Director, President
Brian Harris
Brian Harris
Director, VP Corp Development
Greg S. Reid
Greg S. Reid
Director
Matt Coltura
Matt Coltura
Director
Shabira Rajan, MBA, CPA, CGA
Shabira Rajan, MBA, CPA, CGA
Chief Financial Officer & Controller
Mak Jawadekar, Ph.D.
Mak Jawadekar, Ph.D.
Chief Science Officer
Harry Parekh, Ph.D., MRPharmS
Harry Parekh, Ph.D., MRPharmS
Chief Research Officer
Nicole Goncalves-Krysinski
Nicole Goncalves-Krysinski
Chief Legal Officer
Alicia Rebman
Alicia Rebman
VP, Marketing & Advertising
Sydney Cole
Sydney Cole
Executive Assistant & Office Manager
Deanna Kress
Deanna Kress
Director of Communications & Investor Relations
Ryan Van Deventer
Ryan Van Deventer
Business Development